These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31465299)

  • 1. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
    Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
    Dellon ES; Peterson KA; Murray JA; Falk GW; Gonsalves N; Chehade M; Genta RM; Leung J; Khoury P; Klion AD; Hazan S; Vaezi M; Bledsoe AC; Durrani SR; Wang C; Shaw C; Chang AT; Singh B; Kamboj AP; Rasmussen HS; Rothenberg ME; Hirano I
    N Engl J Med; 2020 Oct; 383(17):1624-1634. PubMed ID: 33085861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis.
    Rubinstein E; Cho JY; Rosenthal P; Chao J; Miller M; Pham A; Aceves SS; Varki A; Broide DH
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):409-16. PubMed ID: 21970996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Gastritis/Gastroenteritis.
    Chen PH; Anderson L; Zhang K; Weiss GA
    Curr Gastroenterol Rep; 2021 Jul; 23(8):13. PubMed ID: 34331146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
    Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
    Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
    Schanin J; Gebremeskel S; Korver W; Falahati R; Butuci M; Haw TJ; Nair PM; Liu G; Hansbro NG; Hansbro PM; Evensen E; Brock EC; Xu A; Wong A; Leung J; Bebbington C; Tomasevic N; Youngblood BA
    Mucosal Immunol; 2021 Mar; 14(2):366-376. PubMed ID: 32814824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
    Farid SSh; Mirshafiey A; Razavi A
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Siglec"ting the allergic response for therapeutic targeting.
    Bochner BS
    Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
    O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
    J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.
    Korver W; Wong A; Gebremeskel S; Negri GL; Schanin J; Chang K; Leung J; Benet Z; Luu T; Brock EC; Luehrsen K; Xu A; Youngblood BA
    Front Immunol; 2022; 13():833728. PubMed ID: 35154156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.
    Hudson SA; Herrmann H; Du J; Cox P; Haddad el-B; Butler B; Crocker PR; Ackerman SJ; Valent P; Bochner BS
    J Clin Immunol; 2011 Dec; 31(6):1045-53. PubMed ID: 21938510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling.
    Song DJ; Cho JY; Lee SY; Miller M; Rosenthal P; Soroosh P; Croft M; Zhang M; Varki A; Broide DH
    J Immunol; 2009 Oct; 183(8):5333-41. PubMed ID: 19783675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic Esophagitis and Gastroenteritis.
    Cianferoni A; Spergel JM
    Curr Allergy Asthma Rep; 2015 Sep; 15(9):58. PubMed ID: 26233430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.